Literature DB >> 26792922

Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer.

Katsuya Watanabe1, Masahiro Tsuboi2, Kentaro Sakamaki3, Teppei Nishii4, Taketsugu Yamamoto4, Takuya Nagashima4, Kohei Ando4, Yoshihiro Ishikawa4, Tekkan Woo4, Hiroyuki Adachi4, Yutaka Kumakiri4, Takamitsu Maehara4, Haruhiko Nakayama4, Munetaka Masuda4.   

Abstract

OBJECTIVES: Our study was designed to visually represent recurrence patterns after surgery for non-small-cell lung cancer (NSCLC) with the use of event dynamics and to clarify postoperative follow-up methods based on the times of recurrence.
METHODS: A total of 829 patients with NSCLC who underwent complete pulmonary resection from 2005 to 2007 in 9 hospitals affiliated with the Yokohama Consortium of Thoracic Surgeons were studied. Event dynamics, based on the hazard rate, were evaluated. Only first events involving the development of distant metastases, local recurrence or both were considered. The effects of sex, histological type, pathological stage and age were studied.
RESULTS: The hazard rate curve displayed an initial surge that peaked about 6-8 months after surgery. The next distinct peak was noted at the end of the second year of follow-up. On non-parametric kernel smoothing, the maximum peak was found 6-8 months after surgery in men. In women, the highest peak occurred 22-24 months after surgery, which was about 16 months later than the peak in men. The peak timing of the hazard curve was not affected by histological type, pathological stage or age in either sex.
CONCLUSIONS: Our results suggest that the timing of recurrence after surgery for lung cancer is characterized by a bimodal pattern, and the times with the highest risk of recurrence were suggested to differ between men and women. Postoperative follow-up strategies should be based on currently recommended follow-up programmes, take into account the recurrence patterns of lung cancer, and be modified as required to meet the needs of individual patients.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Follow-up; Non-small-cell lung cancer; Postoperative; Recurrence dynamics

Mesh:

Year:  2016        PMID: 26792922     DOI: 10.1093/ejcts/ezv462

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  14 in total

Review 1.  Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies.

Authors:  David A Mahvi; Rong Liu; Mark W Grinstaff; Yolonda L Colson; Chandrajit P Raut
Journal:  CA Cancer J Clin       Date:  2018-10-17       Impact factor: 508.702

Review 2.  The Role of PET/CT Molecular Imaging in the Diagnosis of Recurrence and Surveillance of Patients Treated for Non-Small Cell Lung Cancer.

Authors:  Julio Francisco Jiménez-Bonilla; Remedios Quirce; I Martínez-Rodríguez; María De Arcocha-Torres; José Manuel Carril; Ignacio Banzo
Journal:  Diagnostics (Basel)       Date:  2016-09-30

3.  Multicentre randomised phase II study of the perioperative administration of flurbiprofen axetil in patients with non-small cell lung cancer: study protocol of the FLAX Study.

Authors:  Kentaro Sakamaki; Katsuya Watanabe; Tetsukan Woo; Munetaka Masuda
Journal:  BMJ Open       Date:  2020-11-30       Impact factor: 2.692

4.  Remote monitoring of patient recovery following lung cancer surgery: a messenger application approach.

Authors:  Xinghua Cheng; Yunhai Yang; Yang Shentu; Zhengping Ding; Qianjun Zhou; Qiang Tan; Qingquan Luo
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

5.  Machine-Learning-Derived Nomogram Based on 3D Radiomic Features and Clinical Factors Predicts Progression-Free Survival in Lung Adenocarcinoma.

Authors:  Guixue Liu; Zhihan Xu; Yaping Zhang; Beibei Jiang; Lu Zhang; Lingyun Wang; Geertruida H de Bock; Rozemarijn Vliegenthart; Xueqian Xie
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244

6.  Gender Differences in the Recurrence Timing of Patients Undergoing Resection for Non-Small Cell Lung Cancer

Authors:  Katsuya Watanabe; Kentaro Sakamaki; Teppei Nishii; Taketsugu Yamamoto; Takamitsu Maehara; Haruhiko Nakayama; Munetaka Masuda
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

7.  Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery.

Authors:  Tetsuya Isaka; Haruhiko Nakayama; Hiroyuki Ito; Tomoyuki Yokose; Kouzo Yamada; Munetaka Masuda
Journal:  BMC Cancer       Date:  2018-10-05       Impact factor: 4.430

Review 8.  Interpreting Breast Cancer Survival Data by the Hazard Function: Remarkable Findings from Event Dynamics.

Authors:  Romano Demicheli; William Hrushesky; Michael Retsky; Elia Biganzoli
Journal:  Medicina (Kaunas)       Date:  2020-09-12       Impact factor: 2.430

9.  Preoperative inflammation-based scores predict early recurrence after lung cancer resection.

Authors:  Katsuya Watanabe; Daisuke Noma; Haruhiko Masuda; Munetaka Masuda
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

10.  Different pathologic types of early stage lung adenocarcinoma have different post-operative recurrence patterns.

Authors:  Xianping Liu; Kunkun Sun; Fan Yang; Xizhao Sui; Guanchao Jiang; Jun Wang; Xiao Li
Journal:  Thorac Cancer       Date:  2021-06-28       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.